Emiliano Cocco
9PUBLICATIONS
62CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Dec 11, 2025
The Histone Methyltransferase KMT2D Is a Critical Mediator of Lineage Plasticity and Therapeutic Response in Castration-Resistant Prostate Cancer.Srushti Kittane, Erik Ladewig, Taibo Li
|Nov 06, 2025
Dual targeting of RET and SRC synergizes in RET fusion-positive cancer cells.Juhyeon Son, Lily L Remsing Rix, Bin Fang
|Jun 04, 2025
Inhibition of NR2F2 restores hormone therapy response to endocrine refractory breast cancers.Yanyan Cai, Peihua Zhao, Fan Wu
|May 29, 2025
Responsiveness of different MET tumour alterations to type I and type II MET inhibitors.Yonina R Murciano-Goroff, Valentina Foglizzo, Jason Chang
|Jun 20, 2024
Zurletrectinib is a next-generation TRK inhibitor with strong intracranial activity against NTRK fusion-positive tumours with on-target resistance to first-generation agents.Paola Roa, Valentina Foglizzo, Guilherme Harada
|Jun 01, 2023
Response to Repotrectinib After Development of NTRK Resistance Mutations on First- and Second-Generation TRK Inhibitors.Monica F Chen, Soo-Ryum Yang, Jinru Shia
Pageof 2
Frequent Collaborators
4 joint publications
Eneda Toska
3 joint publications
Maurizio Scaltriti
3 joint publications
Alexander Drilon
2 joint publications
Christina S Leslie
2 joint publications
Sarat Chandarlapaty
2 joint publications
Erik Ladewig
2 joint publications
Pau Castel
2 joint publications
Amaia Arruabarrena-Aristorena
1 joint publications
Ino de Bruijn
1 joint publications
James Fagin
